Indrayani Biotech Ltd
INDRANIBIndrayani Biotech Ltd
INDRANIB
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 20.58 | 2.10 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.05 | 9.50 | 1.63% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Indrayani Biotech is engaged in providing travel technology and solutions.
Peers
Compare with peersOracle Financial Services Software Ltd
Persistent Systems Ltd
L&T Technology Services Ltd
Tata Elxsi Ltd
Newgen Software Technologies Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 50.10 | 21.36 | 61.79 | 167.42 | 167.44 | 147.27 | ||||||
Raw Materials | 32.48 | 15.77 | 41.04 | 102.21 | 97.13 | 123.12 | ||||||
| Power & Fuel Cost | 0.48 | 0.33 | 0.34 | 6.08 | 6.70 | |||||||
| Employee Cost | 10.81 | 5.39 | 9.58 | 23.01 | 23.07 | |||||||
| Selling & Administrative Expenses | 2.09 | 3.60 | 2.69 | 7.77 | 6.73 | |||||||
| Operating & Other expenses | 1.26 | 5.05 | 1.15 | 7.04 | 8.94 | |||||||
EBITDA | 2.98 | -8.78 | 6.99 | 21.31 | 24.87 | 24.15 | ||||||
| Depreciation/Amortization | 1.01 | 0.46 | 0.66 | 3.35 | 3.80 | 5.61 | ||||||
| PBIT | 1.97 | -9.24 | 6.33 | 17.96 | 21.07 | 18.54 | ||||||
| Interest & Other Items | 1.15 | 1.97 | 1.89 | 5.64 | 10.10 | 10.59 | ||||||
| PBT | 0.82 | -11.21 | 4.44 | 12.32 | 10.97 | 7.95 | ||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 3.56 | 4.61 | 0.17 | ||||||
| Net Income | 0.82 | -11.21 | 4.44 | 8.76 | 6.36 | 7.78 | ||||||
| EPS | 2.25 | -5.92 | 1.30 | 2.56 | 1.59 | 1.71 | ||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Information TechnologySoftware Services
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Indrayani Biotech Ltd | 25.18 | 2.10 | — |
| Oracle Financial Services Software Ltd | 48.04 | 13.57 | 1.95% |
| Persistent Systems Ltd | 89.63 | 19.77 | 0.41% |
| L&T Technology Services Ltd | 37.91 | 9.24 | 1.07% |
Price Comparison
Compare INDRANIB with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 1.16%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Mar 2024
Apr 2024
Jun 2024
Sep 2024
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
INDRANIB has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNet profit of Indrayani Biotech declined 77.98% to Rs 1.22 crore in the quarter ended September 2024 as against Rs 5.54 crore during the previous quarter ended September 2023. Sales declined 23.81% to Rs 30.81 crore in the quarter ended September 2024 as against Rs 40.44 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales30.8140.44 -24 OPM %16.5918.05 - PBDT3.996.45 -38 PBT1.205.54 -78 NP1.225.54 -78 Powered by Capital Market - Live
Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Net profit of Indrayani Biotech reported to Rs 0.85 crore in the quarter ended June 2024 as against net loss of Rs 0.45 crore during the previous quarter ended June 2023. Sales declined 25.48% to Rs 31.53 crore in the quarter ended June 2024 as against Rs 42.31 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales31.5342.31 -25 OPM %12.625.98 - PBDT1.770.52 240 PBT0.94-0.38 LP NP0.85-0.45 LP Powered by Capital Market - Live
Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
Indrayani Biotech announced that the 32nd Annual General Meeting(AGM) of the company will be held on 22 August 2024.Powered by Capital Market - Live
Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 27 July 2024.Powered by Capital Market - Live
Stocks that will see action today-July 14, 2023
Stocks that will see action on December 8, 2022
Indrayani Biotech-led arm acquires 51% stake in India Home Health Care
Indrayani Biotech delivers two boiler shell profile for T-Special train; Stock jumps 5%
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 8.73%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant